OBJECTIVE:
This study is designed to 1) determine the perceived quality of care received by patients with head and neck cancer at the end of their lives, in order to 2) better anticipate and improve upon the experiences of future patients. METHOD: A prospective, survey-based study was conducted at an academic tertiary care medical center, involving patients who have died of head and neck cancer (nϭ58). A validated survey instrument, the Family Assessment of Treatment at the End of life (FATE), was administered to families of patients who died of head and neck cancer. The primary outcome was the overall FATE score. Independent variables included clinical characteristics, treatments and the care provided at the time of death. RESULTS: Overall FATE scores and the domains assessing management of symptoms and care at the time of death did not vary by disease status (locoregional versus distant metastasis) at the end of life (pϭ.989). The location of death in the home or in hospice (vs. hospital) significantly improves scores in all three categories (pϭ.023). Involvement of a palliative care team improved the care at the time of death (pϽ.001), and palliative treatments (surgery, radiation and/or chemotherapy) improved scores in management of symptoms and care at the time of death (pϭ.011, pϭ.017).
CONCLUSION:
The FATE survey is a useful measure of the end of life experience of head and neck cancer patients. Palliative treatments of head and neck cancer, death outside of the hospital and palliative care team involvement all improve the end of life experience in this population.
Endoscopic Dacryocystorhinostomy after Skull Base Surgery
Jason Moche, MD (presenter); David Hiltzik, MD; Peter Costantino, MD OBJECTIVE: Epiphora is a common sequela of successful endoscopic or open management of anterior skull base lesions. Endoscopic dacryocystorhinostomy (DCR) for management of epiphora in isolated nasolacrimal dysfunction has evolved to become a safe and consistent technique which has replaced open DCR in many centers. We present a series of patients with nasolacrimal dysfunction after anterior craniofacial surgery and describe our management paradigm, including the use of endoscopic DCR. METHOD: Patients with lacrimal dysfunction following endoscopic anterior skull base/craniofacial resection for benign or malignant lesions were identified from a prospective database in a tertiary referral skull base center in a major metropolitan area. Patients treated between January 2001 and present day were identified and a retrospective chart review was performed. Information was collated on the nature of operative intervention for the primary lesion, reconstructive techniques, and the nature and timing of procedures on the nasolacrimal system. Outcome measures included postoperative function of the nasolacrimal system by subjective and objective analysis and the need for revision procedures. 
